Share: Facebook Twitter GooglePLus LinkedIn
Activity Provided By:

CME Outfitters, LLC

Bringing Health Care Providers Together to Diagnose and Treat Idiopathic Pulmonary Fibrosis: A Patient Simulation

Access Activity

Overview / Abstract:

Although the most common of the restrictive lung diseases, idiopathic pulmonary fibrosis (IPF) is a rare but deadly disease, affecting an estimated 6.8 to 42.7 per 100,000 people, with higher rates in those older than 65 years, and resulting in approximately 40,000 deaths annually in the United States.

Education to community pulmonologists, radiologists, and primary care physicians, as well as the multidisciplinary team is important to increase knowledge related to recognition and diagnosis. Clinicians need to be aware of when to refer patients with potential IPF to specialty centers with pulmonologists, radiologists, and pathologists specialized in interstitial lung disease (ILD). All providers in the multidisciplinary and multispecialty treatment team need education related to recent ATS/ERS/JRS/ALAT guidelines and mechanisms of action for the approved treatments for IPF.

In this CME Outfitters decision-tree medical simulation participants will navigate the clinical challenges presented by a patient with IPF. Expert faculty will highlight the latest evidence and guidelines for IPF including when to refer and best treatment approach.


Jul 18, 2018


Clinical Laboratory CE, Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physical Therapy CE, Physician CME, Physician Assistant CME, Respiratory Therapy CE


Online, Performance Improvement, Podcast, Webinar / Webcast / Video

Credits / Hours




Presenters / Authors / Faculty

Steven D. Nathan, MD, FCCP (Moderator)
Medical Director, Lung Transplant Program
Director, Advanced Lung Disease Program
Inova Fairfax Hospital
Professor of Medicine
Virginia Commonwealth University, Inova Fairfax Campus
Falls Church, VA

Jonathan H. Chung, MD
Associate Professor of Radiology
Associate Section Chief, Thoracic Radiology
Director of Thoracic Quality Assurance
The University of Chicago Medicine
Chicago, IL

Marilyn K. Glassberg, MD
Professor of Medicine, Surgery, and Pediatrics
Director, Interstitial Lung Disease Program
Chief, Pulmonary Division at Interdisciplinary Stem Cell Institute
Vice-Chairman of Medicine for Diversity and Innovation
Department of Medicine
University of Miami Miller School of Medicine
Miami, FL

Sponsors / Supporters / Grant Providers

Boehringer Ingelheim Pharmaceuticals, Inc.; Genentech.

Keywords / Search Terms

CME Outfitters, LLC IPF, lung disease, ILD, interstitial lung disease, idiopathic pulmonary fibrosis, pulmonary, pulmonology, pulmonologist, pulmonary fibrosis Free CE CME

Access Activity

RXinsider,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps. RXinsider,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the Terms of Service. Site Map.